HuGE Literature Finder
Records
1
-
3
Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patients. British journal of haematology 2019 May . Mlak Rados?aw, Szudy-Szczyrek Aneta, Mazurek Marcin, Szczyrek Micha?, Homa-Mlak Iwona, Mielnik Micha?, Chocholska Sylwia, Jankowska-??cka Olga, Ma?ecka-Massalska Teresa, Hus Mar |
Polymorphisms in the promoter region of the CRBN gene as a predictive factor for the first-line CTD therapy in multiple myeloma patients. Oncotarget 2018 May 9 (35): 24054-24068. Szudy-Szczyrek Aneta, Mlak Rados?aw, Szczyrek Micha?, Chocholska Sylwia, Sompor Jacek, Nogalski Adam, Ma?ecka-Massalska Teresa, Hus Mar |
Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment. Leukemia research 2015 Oct . Butrym Aleksandra, Rybka Justyna, ?acina Piotr, G?bura Katarzyna, Frontkiewicz Diana, Bogunia-Kubik Katarzyna, Mazur Grzego |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: